KBIO has three Humaneered antibody drugs in clinical trials-- I am simply am amazed that some big money does not come in and load up the truck. Other companies with similar drugs in development have market caps of close to a billion dollars. Just an odd trading stock, any way I look it. Worst stock performance by far in my portfolio, I have had an exceptional track record with 2013 IPOs, batting around .900. Actually the only IPO I've been wrong about is KBIO. I added in here with KBIO, hopefully this gets the ball rolling. I do like the technology, but obviously someone else has not to date. I will check back in a few months.